Scopus
YÖKSİS Eşleşti
Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results from the Phase 3 Randomized Controlled COURAGE Trial
Journal of Urology · Kasım 2024
YÖKSİS Kayıtları
Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial
Journal of Urology · 2024 SCI-Expanded
DOÇENT MURAT GÜL →
Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial
Journal of Urology · 2024 SCI-Expanded
DOÇENT ALİ FURKAN BATUR →
Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial
Journal of Urology · 2024 SCI-Expanded
DOÇENT EMRE ALTINTAŞ →
Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial
Journal of Urology · 2024 SCI-Expanded
DOÇENT EMRE ALTINTAŞ →
Makale Bilgileri
DergiJournal of Urology
Yayın TarihiKasım 2024
Cilt / Sayfa212 · 758-759
Scopus ID2-s2.0-85200323854
Yazarlar (3)
1
Ali Furkan Batur
ORCID: 0000-0001-7945-7326
2
Emre Altıntaş
ORCID: 0000-0002-6797-3937
3
Murat Gul
ORCID: 0000-0002-6657-6227
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey